Published in Eur Respir J on August 06, 2010
Effect of CPAP on 6-Minute Walk Test Outcomes in Patients With ECAC | NCT04217603
Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ (2012) 4.19
The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 3.24
Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax (2014) 1.62
Physical Activity Counselling during Pulmonary Rehabilitation in Patients with COPD: A Randomised Controlled Trial. PLoS One (2015) 1.56
A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J (2015) 1.45
Long-term follow-up after bronchoscopic lung volume reduction treatment with coils in patients with severe emphysema. Respirology (2014) 1.44
The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med (2013) 1.23
Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials. Respir Res (2014) 0.99
Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial). Am J Cardiol (2013) 0.98
Daily step count predicts acute exacerbations in a US cohort with COPD. PLoS One (2013) 0.98
Simple functional performance tests and mortality in COPD. Eur Respir J (2013) 0.97
Effects of Tai Chi in patients with chronic obstructive pulmonary disease: preliminary evidence. PLoS One (2013) 0.95
Effects of yoga training in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Thorac Dis (2014) 0.93
A framework for organizing and selecting quantitative approaches for benefit-harm assessment. BMC Med Res Methodol (2012) 0.90
Responsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPD. Pulm Med (2013) 0.89
The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis--a randomised controlled trial. Respir Res (2014) 0.87
Long-term effects of gastrectomy in patients with spirometry-defined COPD and patients at risk of COPD: a case-control study. Int J Chron Obstruct Pulmon Dis (2015) 0.87
Optimizing the 6-min walk test as a measure of exercise capacity in COPD. Chest (2012) 0.86
Outcome of pulmonary rehabilitation in COPD patients with severely impaired health status. Int J Chron Obstruct Pulmon Dis (2011) 0.86
Low intensity, long-term outpatient rehabilitation in COPD: a randomised controlled trial. Respir Res (2012) 0.85
Reproducibility of the six-minute walk test and Glittre ADL-test in patients hospitalized for acute and exacerbated chronic lung disease. Braz J Phys Ther (2015) 0.85
Determinants of successful completion of pulmonary rehabilitation in COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.84
Health status measured by the Clinical COPD Questionnaire (CCQ) improves following post-acute pulmonary rehabilitation in patients with advanced COPD: a prospective observational study. NPJ Prim Care Respir Med (2014) 0.82
Inspiratory muscle training protocol for patients with chronic obstructive pulmonary disease (IMTCO study): a multicentre randomised controlled trial. BMJ Open (2013) 0.82
Effects of Tai Chi on exercise capacity and health-related quality of life in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis (2014) 0.81
The Minimal Important Difference in Physical Activity in Patients with COPD. PLoS One (2016) 0.80
Domain-specific self-efficacy is associated with measures of functional capacity and quality of life among patients with moderate to severe chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 0.80
Six-minute stepper test: a valid clinical exercise tolerance test for COPD patients. Int J Chron Obstruct Pulmon Dis (2016) 0.79
Feasibility and effectiveness of a home-based exercise training program before lung resection surgery. Can Respir J (2013) 0.79
Prescribing exercise interventions for patients with chronic conditions. CMAJ (2016) 0.78
Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD. Lung (2016) 0.77
Chinese Herbal Medicine and Salmeterol and Fluticasone Propionate for Chronic Obstructive Pulmonary Disease: Systematic Review and Network Meta-Analysis. Medicine (Baltimore) (2016) 0.77
Correlation of cardiopulmonary exercise testing parameters with quality of life in stable COPD patients. J Thorac Dis (2016) 0.77
Chronic disease self-management and exercise in COPD as pulmonary rehabilitation: a randomized controlled trial. Int J Chron Obstruct Pulmon Dis (2014) 0.77
How important is a minimal difference? Eur Respir J (2011) 0.77
Bronchoscopic lung volume reduction by endobronchial valve in advanced emphysema: the first Asian report. Int J Chron Obstruct Pulmon Dis (2015) 0.76
Minimal clinically important difference for the 6-min walk test: literature review and application to Morquio A syndrome. Orphanet J Rare Dis (2017) 0.75
Comparison of laboratory- and field-based exercise tests for COPD: a systematic review. Int J Chron Obstruct Pulmon Dis (2015) 0.75
One-Year Follow-Up after Endobronchial Valve Treatment in Patients with Emphysema without Collateral Ventilation Treated in the STELVIO Trial. Respiration (2016) 0.75
Coil therapy for patients with severe emphysema and bilateral incomplete fissures - effectiveness and complications after 1-year follow-up: a single-center experience. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Clinical and radiological outcome following pneumothorax after endoscopic lung volume reduction with valves. Int J Chron Obstruct Pulmon Dis (2016) 0.75
The 6-minute Walk Test as a COPD Stratification Tool: Insights From the COPD Biomarker Qualification Consortium. Am J Respir Crit Care Med (2016) 0.75
The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension. Ann Am Thorac Soc (2016) 0.75
The Effects of Traditional Chinese Exercise in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis. PLoS One (2016) 0.75
A randomized controlled trial of telephone-mentoring with home-based walking preceding rehabilitation in COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Smallest worthwhile effect of land-based and water-based pulmonary rehabilitation for COPD. ERJ Open Res (2015) 0.75
The minimal important difference of the pulmonary functional status and dyspnea questionnaire in patients with severe chronic obstructive pulmonary disease. Respir Res (2013) 0.75
ProKaSaRe Study Protocol: A Prospective Multicenter Study of Pulmonary Rehabilitation of Patients With Sarcoidosis. JMIR Res Protoc (2015) 0.75
Limitations of calculating "true" regression slope: impact on estimates of minimal important difference. Eur Respir J (2011) 0.75
Exercise training for asbestos-related and other dust-related respiratory diseases: a randomised controlled trial. BMC Pulm Med (2014) 0.75
Functional Status Assessment of Patients With COPD: A Systematic Review of Performance-Based Measures and Patient-Reported Measures. Medicine (Baltimore) (2016) 0.75
Early Trends in Bronchoscopic Lung Volume Reduction: A Systematic Review and Meta-analysis of Efficacy Parameters. Lung (2016) 0.75
Variability in objective and subjective measures affects baseline values in studies of patients with COPD. PLoS One (2017) 0.75
Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial. BMJ Open (2017) 0.75
The Influence of Body Composition on Pulmonary Rehabilitation Outcomes in Chronic Obstructive Pulmonary Disease Patients. Lung (2017) 0.75
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med (2003) 10.40
The St George's Respiratory Questionnaire. Respir Med (1991) 8.49
Methods to explain the clinical significance of health status measures. Mayo Clin Proc (2002) 7.00
Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet (2009) 5.51
Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol (1999) 4.90
What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes (2003) 3.42
Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med (1997) 3.28
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J (2004) 2.63
Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest (1998) 2.57
Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 2.50
Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes (2006) 2.48
Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD (2005) 2.14
The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes (2008) 2.07
Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J (2008) 1.82
Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J (2006) 1.77
Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med (2008) 1.76
Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol (2003) 1.75
Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD (2005) 1.68
Commentary--goodbye M(C)ID! Hello MID, where do you come from? Health Serv Res (2005) 1.63
Minimal clinically important difference for the UCSD Shortness of Breath Questionnaire. J Cardiopulm Rehabil (2005) 1.47
Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respir Med (2006) 1.45
Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg (1999) 1.29
The effects of short-term and long-term pulmonary rehabilitation on functional capacity, perceived dyspnea, and quality of life. Chest (2005) 1.05
Pulmonary exercise testing predicts prognosis in patients with chronic obstructive pulmonary disease. Intern Med (2005) 0.91
Maximum exercise as an outcome in COPD: minimal clinically important difference. COPD (2005) 0.89
A psychomotor stimulant theory of addiction. Psychol Rev (1987) 6.42
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene (2006) 5.86
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature (2001) 5.14
Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis (1992) 4.19
Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest (2000) 3.75
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J (2004) 3.19
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia (1973) 2.48
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol (1985) (1988) 2.34
Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol (1985) (1988) 2.20
Prevalence and clinical correlates of bronchoreversibility in severe emphysema. Eur Respir J (2009) 2.18
Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am Rev Respir Dis (1991) 2.16
Recurrent paroxysmal cold haemoglobinuria in a 3-year-old child: a case report. Transfus Med (2003) 2.01
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med (1996) 1.96
Crystal structure and mutational analysis of a perlecan-binding fragment of nidogen-1. Nat Struct Biol (2001) 1.96
Complex procedural skills are retained for a minimum of 1 yr after a single high-fidelity simulation training session. Br J Anaesth (2011) 1.91
Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis (1991) 1.89
Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med (1994) 1.83
Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med (2000) 1.79
Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med (2007) 1.77
Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci (1981) 1.77
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest (1993) 1.70
The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol (1988) 1.65
Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J Biol Chem (2000) 1.59
Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food. Science (1978) 1.59
Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum (1992) 1.59
Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA (1985) 1.57
Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci (1996) 1.53
Myasthenia gravis and upper airway obstruction. Chest (1996) 1.51
Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med (1995) 1.50
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med (1994) 1.50
Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science (1975) 1.49
Pulmonary function and respiratory chemosensitivity in moderately obese patients with sleep apnea. Chest (1993) 1.49
Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology (Berl) (1976) 1.43
Typhoid fever in the park: epidemiology of an outbreak at a cultural interface. J Community Health (1995) 1.42
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med (1994) 1.42
Characterization of a type IV collagen major cell binding site with affinity to the alpha 1 beta 1 and the alpha 2 beta 1 integrins. J Cell Biol (1991) 1.41
Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurons of the ventral tegmental area. J Neurosci (2000) 1.41
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol (1992) 1.41
Thermochemistry of gaseous ammonium nitrate, NH4NO3(g). J Phys Chem B (2010) 1.39
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther (1993) 1.38
Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol (1977) 1.38
Habit-forming actions of nomifensine in nucleus accumbens. Psychopharmacology (Berl) (1995) 1.36
Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci (1994) 1.35
Catecholamine theories of reward: a critical review. Brain Res (1978) 1.35
Action of drugs of abuse on brain reward systems: an update with specific attention to opiates. Pharmacol Biochem Behav (1982) 1.34
Both positive reinforcement and conditioned aversion from amphetamine and from apomorphine in rats. Science (1976) 1.34
Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. Am J Respir Crit Care Med (1998) 1.33
Persistent pneumomediastinum in interstitial fibrosis associated with rheumatoid arthritis: treatment with high-concentration oxygen. Chest (2000) 1.33
Pulmonary gas exchange in humans during exercise at sea level. J Appl Physiol (1985) (1986) 1.31
The effect of anthropometric and socioeconomic factors on the racial difference in lung function. Am J Respir Crit Care Med (2001) 1.29
Tracheal and neck position influence upper airway airflow dynamics by altering airway length. J Appl Physiol (1985) (1993) 1.28
Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain: a moveable electrode mapping study. Brain Res (1980) 1.28
Neural mechanisms of the reinforcing action of cocaine. NIDA Res Monogr (1984) 1.27
Pharmacological regulation of intravenous cocaine and heroin self-administration in rats: a variable dose paradigm. Pharmacol Biochem Behav (1989) 1.26
Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens. Synapse (1999) 1.26
Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous D-amphetamine self-administration. J Neurosci (1999) 1.26
Mechanism of decreased left ventricular stroke volume during inspiration in man. Circulation (1984) 1.25
Novelty-evoked elevations of nucleus accumbens dopamine: dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission in the ventral tegmental area. Eur J Neurosci (2001) 1.25
Pulmonary gas exchange in humans during normobaric hypoxic exercise. J Appl Physiol (1985) (1986) 1.23
Incidence of lung cancer in systemic sclerosis. J Rheumatol (1985) 1.22
Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. J Neurosci (1998) 1.21
Effect of electrical stimulation of the hypoglossal nerve on airflow mechanics in the isolated upper airway. Am Rev Respir Dis (1993) 1.18
The effect of gender on the relationship between body fat distribution and lung function. J Clin Epidemiol (2001) 1.16
Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav (1991) 1.15
African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest (1998) 1.14
Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation. Neuroscience (2001) 1.13
Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. Lung Health Study Research Group. J Clin Epidemiol (1998) 1.13
Anti-inflammatory and anti-arthritic activity of volatile oil of Curcuma longa (Haldi). Indian J Med Res (1972) 1.11
Acute exacerbations of chronic bronchitis: an international comparison. Chest (1998) 1.11
Heroin reward is dependent on a dopaminergic substrate. Life Sci (1981) 1.10
Effect of positive nasal pressure on upper airway pressure-flow relationships. J Appl Physiol (1985) (1989) 1.10
Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward. Psychopharmacology (Berl) (1996) 1.09
Medical surveillance for occupational respiratory diseases. J Occup Med (1975) 1.08
Impact of guinea worm disease on children in Nigeria. Am J Trop Med Hyg (1986) 1.08
Prevalence and molecular characterization of bovine Cryptosporidium isolates in India. Vet Parasitol (2008) 1.06
Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits. Brain Res (1976) 1.04
Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine. J Neurosci (2001) 1.04
Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science (1984) 1.03
Reflex modulation of airflow dynamics through the upper airway. J Appl Physiol (1985) (1994) 1.02
Effects of pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement. J Neurosci (1998) 1.01
Effects of abdominal pressure on venous return: abdominal vascular zone conditions. J Appl Physiol (1985) (1990) 1.01
Environment-specific cross-sensitization between the locomotor activating effects of morphine and amphetamine. Pharmacol Biochem Behav (1989) 1.01
Treatment of capsulitis of the shoulder. Rheumatol Rehabil (1975) 1.01
Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J Neurosci (1994) 1.01
Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J (2009) 1.00
Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine (Baltimore) (1984) 1.00
Comparative evaluation and economic assessment of coprological diagnostic methods and PCR for detection of Cryptosporidium spp. in bovines. Vet Parasitol (2009) 0.99
Trace and contextual fear conditioning is enhanced in mice lacking the alpha4 subunit of the GABA(A) receptor. Neurobiol Learn Mem (2009) 0.99
Mechanism of reduced LV afterload by systolic and diastolic positive pleural pressure. J Appl Physiol (1985) (1988) 0.99
Augmentation of cardiac function by elevation of intrathoracic pressure. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.99
Brain reward circuitry: four circuit elements "wired" in apparent series. Brain Res Bull (1984) 0.98
Influence of cytotoxic doses of 4-hydroxynonenal on selected neurotransmitter receptors in PC-12 cells. Toxicol In Vitro (2008) 0.98
Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. Am J Med (1984) 0.97